lactic acid has been researched along with dipyridamole in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hosoyamada, A; Kuno, M; Negishi, H; Suzuki, T; Yasumoto, K | 1 |
| Banker, MC; Hicks, GL; Pearce, F; Tibi, P | 1 |
| Blaise, G; Boulanger, Y; Cardoso, M; Gougoux, A; Léveillé, M; Noël, J; Prud'homme, M; Vinay, P; Vinet, B | 1 |
| Duwel, CM; Karreman, AJ; Roos, JP; van Eenige, MJ; van Lingen, A; Visser, FC | 1 |
| Dahms, TE; Pearse, DB; Wagner, EM | 1 |
| Bae, YH; Cheung, AK; Kern, SE; Masaki, T; Rathi, R; Zhu, W | 1 |
| Lambov, N; Miloshev, S; Yoncheva, K | 1 |
| Fatouros, DG; Gioti, M; Karagiannidis, PG; Karagkiozaki, V; Logothetidis, S; Vavoulidis, E; Vizirianakis, IS | 1 |
9 other study(ies) available for lactic acid and dipyridamole
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Changes in myocardial blood flow and systemic hemodynamics during hypotensive anesthesia induced by adenosine triphosphate with or without dipyridamole].
Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Dipyridamole; Dogs; Hemodynamics; Hypotension, Controlled; Lactates; Lactic Acid; Uric Acid | 1992 |
Metabolic and functional cardiac impairment after reperfusion with persantine.
Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Dipyridamole; Heart; Heart Arrest; Hemodynamics; Hyperkalemia; Lactates; Lactic Acid; Myocardial Reperfusion; Myocardium; Purines; Rabbits | 1991 |
Metabolic effects of acetate on the heart.
Topics: Acetates; Acetic Acid; Adenosine; Adenosine Triphosphate; Animals; Chromatography, High Pressure Liquid; Coronary Circulation; Dipyridamole; Glucose; Heart; Lactates; Lactic Acid; Magnetic Resonance Spectroscopy; Myocardium; Phosphates; Pyruvates; Pyruvic Acid; Rats; Rats, Inbred Strains; Theophylline; Vasodilation | 1989 |
Comparison of 17-iodine-131 heptadecanoic acid kinetics from externally measured time-activity curves and from serial myocardial biopsies in an open-chest canine model.
Topics: Animals; Dipyridamole; Dogs; Fatty Acids; Glucose; Heart; Iodine Radioisotopes; Lactates; Lactic Acid; Myocardium; Norepinephrine; Radionuclide Imaging | 1988 |
Microsphere-induced bronchial artery vasodilation: role of adenosine, prostacyclin, and nitric oxide.
Topics: Adenine Nucleotides; Adenosine; Animals; Bronchial Arteries; Dipyridamole; Enzyme Inhibitors; Epoprostenol; Lactic Acid; Microspheres; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Sheep; Vasodilation; Xanthines | 1998 |
Development of a sustained-release system for perivascular delivery of dipyridamole.
Topics: Animals; Biocompatible Materials; Blood Vessels; Delayed-Action Preparations; Dipyridamole; Drug Carriers; Drug Delivery Systems; Humans; Lactic Acid; Materials Testing; Microspheres; Molecular Weight; Particle Size; Platelet Aggregation Inhibitors; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Surface Properties; Swine; Viscosity | 2006 |
Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol.
Topics: Delayed-Action Preparations; Dipyridamole; Drug Compounding; Drug Delivery Systems; Drug Stability; Kinetics; Lactic Acid; Malates; Microspheres; Molecular Weight; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solvents | 2009 |
Development of a nanoporous and multilayer drug-delivery platform for medical implants.
Topics: Biocompatible Materials; Blood Platelets; Cells, Cultured; Crystallization; Dipyridamole; Drug-Eluting Stents; Humans; Lactic Acid; Nanocapsules; Particle Size; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Prosthesis Design; Treatment Outcome | 2012 |